Merck KGaA (MRK) News Today €130.55 +1.60 (+1.24%) As of 03/28/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period MRK Investors Have Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLPMarch 29 at 10:04 AM | markets.businessinsider.comWhy Merck & Co. Inc. (MRK) Went Up On Friday?March 29 at 12:02 AM | msn.comMerck announces EC approved Capvaxive pneumococcal vaccineMarch 28 at 12:02 AM | markets.businessinsider.comMerck says 3475A-D77 Phase 3 trial met primary endpointsMarch 27 at 6:59 PM | markets.businessinsider.comMerck licenses HRS-5346 in cardiovascular disease from Hengrui PharmaMarch 26, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Shares Up 0.1% - Here's WhyMerck KGaA (ETR:MRK) Shares Up 0.1% - Time to Buy?March 16, 2025 | marketbeat.comThere May Be Some Bright Spots In Merck KGaA's (ETR:MRK) EarningsMarch 14, 2025 | finance.yahoo.comMerck says DOR/ISL met primary efficacy success criterion in two Phase 3 trialsMarch 13, 2025 | markets.businessinsider.comMerck scores victory in Gardasil lawsuits as judge questions evidenceMarch 13, 2025 | msn.comMerck releases positive phase 3 data on daily oral HIV drugMarch 13, 2025 | msn.comMerck prevails in US safety litigation over Gardasil HPV vaccineMarch 12, 2025 | msn.comMerck & Company (MRK) Gets a Buy from Berenberg BankMarch 12, 2025 | markets.businessinsider.comMerck wins Gardasil litigation over cancer vaccine risksMarch 11, 2025 | au.investing.comMerck opens manufacturing facility in North Carolina amid Trump's tariff threatsMarch 11, 2025 | msn.comFederal Judge Rules in Merck’s Favor in Gardasil Safety SuitMarch 11, 2025 | msn.comJudge rules in Merck’s favor over Gardasil complaints, Bloomberg saysMarch 11, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Has Announced A Dividend Of €2.20March 9, 2025 | finance.yahoo.comMerck KGaA Full Year 2024 Earnings: EPS Misses ExpectationsMarch 7, 2025 | finance.yahoo.comMerck KGaA (ETR:MRK) shareholders have earned a 8.1% CAGR over the last five yearsMarch 6, 2025 | finance.yahoo.comMerck’s Keytruda subject of brewing patent dispute with Halozyme, WSJ saysMarch 6, 2025 | markets.businessinsider.comMerck KGaA 2024 Sales EUR21.16BMarch 6, 2025 | marketwatch.comMerck's (NYSE:MRK) Earnings May Just Be The Starting PointMarch 4, 2025 | finance.yahoo.comRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business ofFebruary 28, 2025 | finanznachrichten.deMerck price target lowered to $115 from $125 at BerenbergFebruary 28, 2025 | markets.businessinsider.comMerck expects Keytruda to face HHS price setting in 2026February 27, 2025 | msn.comMerck set to snap six straight sessions of gainsFebruary 26, 2025 | seekingalpha.comDespite delivering investors losses of 27% over the past 1 year, Merck (NYSE:MRK) has been growing its earningsFebruary 26, 2025 | finance.yahoo.comUS drugmaker Merck to boost workforce in India, executive saysFebruary 26, 2025 | msn.comMerck's Oncology Strength: Beating Wall Street AgainFebruary 26, 2025 | seekingalpha.comMerck’s application for keytruda in HNSCC granted priority review by FDAFebruary 25, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Trading 0.7% Higher - Should You Buy?Merck KGaA (ETR:MRK) Shares Up 0.7% - Time to Buy?February 23, 2025 | marketbeat.comMRK INVESTOR DEADLINE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitFebruary 20, 2025 | markets.businessinsider.comMerck wins EU nod for Welireg against two kidney cancer indicationsFebruary 19, 2025 | seekingalpha.comMerck downgraded to Hold from Buy at Deutsche BankFebruary 18, 2025 | markets.businessinsider.comDeutsche downgrades Merck ahead of Keytruda 2028 expirationFebruary 18, 2025 | markets.businessinsider.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRKFebruary 14, 2025 | markets.businessinsider.comMerck & Company, Inc. (MRK) Stock ForecastsFebruary 13, 2025 | finance.yahoo.comGermany's Merck in Advanced Talks to Acquire US Biotech Firm SpringWorksFebruary 11, 2025 | msn.comSpringWorks Therapeutics jumps on report of Merck KGaA takeover talks (update)February 11, 2025 | seekingalpha.comMerck stock price target lowered to $95 by Bernstein SocGenFebruary 11, 2025 | msn.comMerck price target lowered to $112 from $118 at BofAFebruary 5, 2025 | markets.businessinsider.comWells Fargo Remains a Hold on Merck & Company (MRK)February 5, 2025 | markets.businessinsider.comMerck KGaA (ETR:MRK) Shares Up 2% - Time to Buy?Merck KGaA (ETR:MRK) Trading Up 2% - What's Next?February 1, 2025 | marketbeat.comMerck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in AdultsJanuary 31, 2025 | uk.finance.yahoo.comMerck’s capvaxive receives positive EU CHMP opinion for pneumococcal vaccineJanuary 31, 2025 | markets.businessinsider.comMerck's CAPVAXIVE Gets Positive EU CHMP Opinion For Pneumococcal Vaccination In AdultsJanuary 31, 2025 | markets.businessinsider.comMerck gets priority review for Welireg for PPGLJanuary 27, 2025 | seekingalpha.comMerck's SWOT analysis: stock outlook amid oncology competition, pipeline growthJanuary 25, 2025 | msn.comMerck, Eisai post mixed Phase 3 data for Keytruda/ Lenvima in GIT cancerJanuary 24, 2025 | msn.comMerck price target lowered to $113 from $123 at Morgan StanleyJanuary 21, 2025 | markets.businessinsider.com Remove Ads Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address MRK Media Mentions By Week MRK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.140.81▲Average Medical News Sentiment MRK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼54▲MRK Articles Average Week Remove Ads Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Today ad pepper media International News Today Genfit News Today Evotec News Today Siemens Healthineers News Today Bayer Aktiengesellschaft News Today Fresenius Medical Care News Today Carl Zeiss Meditec News Today Gerresheimer News Today CompuGroup Medical SE & Co. KGaA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MRK) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
